If Your Insurer Covers Few Therapists, Is That Really Mental Health Parity?
(By Jenny Gold for California Healthline produced by Kaiser Health News) It’s been nearly a decade since Congress passed the mental
Read More
Health Care – General
Even Low-Dose Contraceptives Slightly Increase Breast Cancer Risk
(By Patti Neighmond for NPR) It’s long been known that hormonal contraception, like any medicine, carries some risks. But doctors
Read MoreStudy: Uninsured patients aren’t overusing the ER — 4 things to know
(By Megan Knowles for Becker’s Hospital Review) Uninsured adults use emergency rooms at similar rates to insured adults, contrary to
Read MoreThe 109 Leapfrog Top Hospital awardees for 2017
(By Brian Zimmerman for Becker’s Hospital Review) The Leapfrog Group on Thursday named the recipients of its 2017 Top Hospital
Read MoreDoctor out sick? A substitute physician is no worse for patients’ health
(By Max Blau for STAT) It’s long been thought that hospitalized patients are better off getting treatment from full-time doctors
Read MoreNew Drugs Could Prevent Migraine Headaches For Some People
(By Jon Hamilton for NPR) People who experience frequent migraines may soon have access to a new class of drugs.
Read MoreIf Your Insurer Covers Few Therapists, Is That Really Mental Health Parity?
(By Jenny Gold for Kaiser Health News) It’s been nearly a decade since Congress passed the mental health parity act,with its
Read MoreMost Americans with high-deductible health plans don’t shop for care: 5 things to know
(By Morgan Haefner for Becker’s Hospital Review) Few Americans with high-deductible health plans are comparing prices when accessing healthcare treatment,
Read MoreCongressional inaction threatens states’ CHIP funding: 5 things to know
(By Kelly Gooch for Becker’s Hospital Review) States are bracing to potentially lose Children’s Health Insurance Program funding amid federal
Read MoreScientist concedes his controversial MS therapy, once a source of great hope, is ‘largely ineffective’
(By Helen Branswell for STAT) What many hope will be the final chapter in an unfortunate saga in multiple sclerosis research appears
Read More